Virological and immunological monitoring of the four groups of solid-organ transplant recipients with or without HCMV infection reactivation.

Abstract

<p>NA, not applicable.</p>1<p>Follow-up.</p>2<p>Patients of this group showed HCMV specific CD8⁺ only, until about 3 months after transplantation, then developed HCMV-specific CD4⁺ T-cells.</p>3<p>In some cases, clinicians preferred initiating antiviral therapy after reaching 100,000 (instead of 300,000) DNA copies/ml blood due to presence of end-organ disease.</p><p>Virological and immunological monitoring of the four groups of solid-organ transplant recipients with or without HCMV infection reactivation.</p